These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27068176)

  • 21. Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis.
    Kim TH; Kim JY; Mun HS; Lee HY; Roh YH; Uhm JS; Pak HN; Lee MH; Joung B
    J Thromb Haemost; 2015 Feb; 13(2):182-90. PubMed ID: 25472735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
    Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
    J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation is unnecessary after biological aortic valve replacement.
    Moinuddeen K; Quin J; Shaw R; Dewar M; Tellides G; Kopf G; Elefteriades J
    Circulation; 1998 Nov; 98(19 Suppl):II95-8; discussion II98-9. PubMed ID: 9852888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience.
    Gurevich S; Oestreich B; Kelly RF; Mbai M; Bertog S; Yannopoulos D; Garcia S
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):621-625. PubMed ID: 29276174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
    Jaffer AK; Brotman DJ; Bash LD; Mahmood SK; Lott B; White RH
    Am J Med; 2010 Feb; 123(2):141-50. PubMed ID: 20103023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is long-term warfarin therapy necessary in Chinese patients with atrial fibrillation after bioprosthetic mitral valve replacement and left atrial appendage obliteration?
    Zhang L; Jiang S; Ren C; Gao C
    Heart Surg Forum; 2015 Feb; 18(1):E11-6. PubMed ID: 25881216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
    Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD
    Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
    Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison on efficacy and safety of different bridging anticoagulation therapies in patients undergoing mechanical heart valve replacement surgery].
    Liu SD; Qi L; Li BX; Li X; Fang T; Song B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Feb; 48(2):130-135. PubMed ID: 32135613
    [No Abstract]   [Full Text] [Related]  

  • 35. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
    Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
    Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.
    Chan WS; Anand S; Ginsberg JS
    Arch Intern Med; 2000 Jan; 160(2):191-6. PubMed ID: 10647757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dabigatran versus warfarin in patients with mechanical heart valves.
    Eikelboom JW; Connolly SJ; Brueckmann M; Granger CB; Kappetein AP; Mack MJ; Blatchford J; Devenny K; Friedman J; Guiver K; Harper R; Khder Y; Lobmeyer MT; Maas H; Voigt JU; Simoons ML; Van de Werf F;
    N Engl J Med; 2013 Sep; 369(13):1206-14. PubMed ID: 23991661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical heart valves: a tertiary hospital-based study in Botswana.
    Botsile E; Mwita JC
    Cardiovasc J Afr; 2020; 31(4):185-189. PubMed ID: 32181794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.